Phenibut vs Sabroxy (Oroxylum indicum)

Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.

PhenibutSabroxy (Oroxylum indicum)
CategoryNootropicsNootropics
Standard Dose250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)
TimingOn an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.
Cycle DurationSTRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.
Evidence Levelmoderate_humanEmerging
A

Phenibut

Nootropics

Mechanism

Beta-phenyl derivative of GABA that crosses the blood-brain barrier (unlike GABA itself) due to the addition of a phenyl ring. Acts as a full agonist at GABA-B receptors with 30-68x lower affinity than baclofen, requiring correspondingly higher doses. Also binds to and blocks alpha-2-delta subunit-containing voltage-dependent calcium channels (VDCCs), making it a gabapentinoid similar to gabapentin and pregabalin. At low concentrations, mildly increases dopamine levels in the brain, providing stimulatory and nootropic effects alongside anxiolysis. Weak agonist activity at GABA-A receptors at higher doses.

Standard Dosing

250-750 mg as needed, maximum 1-2 times per week (for educational context — carries significant dependence risk)

Timing

On an empty stomach (food significantly reduces absorption). Onset 2-4 hours. Effects last 4-8 hours with residual effects up to 24 hours. Half-life approximately 5.3 hours.

Cycle Duration

STRICTLY intermittent use only — maximum 1-2 times per week. NEVER use daily for more than 1 week. Tolerance develops within days, leading to dose escalation and dependence.

Side Effects

  • Drowsiness/sedation
  • Dizziness
  • Nausea
  • Tolerance (develops rapidly)
  • Physical dependence (can occur within 1-2 weeks of daily use)
  • Withdrawal syndrome (anxiety, insomnia, tremor, psychosis, hallucinations, seizures)
  • Hangover effect
  • Motor incoordination at high doses

Contraindications

  • History of substance use disorder
  • Epilepsy
  • Renal impairment (primarily renally excreted)
  • Concurrent use of any CNS depressant
  • Pregnancy and lactation
  • Severe hepatic impairment
  • History of benzodiazepine or alcohol dependence

Best Stacking Partners

L-Theanine (for mild synergy without adding dependence risk)

Mechanism

Contains oroxylin A — a flavonoid that inhibits PDE (phosphodiesterase), increases BDNF, and modulates dopamine signaling. Enhances focus and motivation without stimulant side effects. Also acts as a mild MAO-B inhibitor, preserving dopamine levels.

Contraindications

  • Concurrent MAO inhibitors

Not sure which is right for you?

Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.

Get Your Free Protocol →or take the assessment →